Showing results for "Achaogen"
technology
Deadly Superbugs Win as Wall Street Flees Makers of AntibioticsFour years ago, antibiotics developer Tetraphase Pharmaceuticals Inc. had a market value of almost $2 billion. Now its shares trade for about 70 cents as investors flee the market for new drugs that kill bacterial infections.June 17, 2019
business
Biden's Son Employed in Profession Obama Disdains: LobbyingBarack Obama's speech announcing his running mate Joe Biden singled out the Delaware senator's son who is headed for Iraq. Obama didn't mention the profession of Biden's other son, who lobbied for two drug companies and five universities.August 24, 2008